Pharma firm Granules India plunges after USFDA scrutiny

Alembic Pharmaceuticals

09/09/2024 04:52

** Shares of Granules India  GRAN.NS  down 3.5% to 665
rupees 
    ** The pharma firm said U.S. FDA inspection at its Hyderabad
facility concluded with six observations 
    ** Stock fell 4.2% last week, while peer Aurobindo Pharma
 ARBN.NS  dropped 2.04% and Alembic Pharma  ALEM.NS  gained 4.4%

 (Reporting by Manvi Pant in Bengaluru)
 ((Manvi.Pant@thomsonreuters.com; +918447554364;))